Skip to content

Clinical trials

Phase 2 Glomerulonephritis, IGA trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis, IGA Phase: Phase 2 Country / region: Hong Kong Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20161
20181
20201
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ADARx Pharmaceuticals, Inc.1
Novartis Pharmaceuticals1
Omeros Corporation1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Rigel Pharmaceuticals1
Travere Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis, IGA6
Autoimmune Diseases1
Glomerulonephritis1
Glomerulonephritis, Membranous1
Immune System Diseases1
Kidney Diseases1
Lupus Nephritis1
Nephritis1
Proteinuria1
Renal Insufficiency, Chronic1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.